Fortress Biotech 9.375% Series A Preferred Stock
FBIOP
1 hedge funds and large institutions have $611K invested in Fortress Biotech 9.375% Series A Preferred Stock in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
2.29% more ownership
Funds ownership: 0% → 2.29% (+2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Shikiar Asset Management
New York
|
+$614K |
Top Sellers
FBIOP Hedge Fund Activity: Q4 2019 in Review
1 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech 9.375% Series A Preferred Stock (FBIOP) for Q4 2019, worth a combined $611K.
Buyers outnumbered sellers: 1 fund opened new FBIOP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Shikiar Asset Management, opening a new position worth an estimated $614K.
- 1 institutional investor held Fortress Biotech 9.375% Series A Preferred Stock (FBIOP) as of Q4 2019, up from 0 in Q3 2019.
- Funds reported $611K of Fortress Biotech 9.375% Series A Preferred Stock stock for Q4 2019.
- 1 fund opened new Fortress Biotech 9.375% Series A Preferred Stock positions in Q4 2019 and 0 closed out, a net change of +1 holder.
- The largest Fortress Biotech 9.375% Series A Preferred Stock buyer in Q4 2019 was Shikiar Asset Management, an estimated $614K added.
Based on aggregated 13F filings for Q4 2019.